Evidence map›Paper›PMID 29774671›Full record

ArticleThe world journal of men's health2018

Is It Worth Treating Non-Bothering Nocturia? Results of a Multicenter Prospective Observational Study.

Kwangsung Park, Hyoung Keun Park, Sae Woong Kim, Dae Yul Yang, Jong Kwan Park, Hyun Jun Park, Ki Hak Moon, Du Geon Moon, Kweon Sik Min, Hwancheol Son and 4 more

Open access · diamondAbstract read
In one paragraph

Article in The world journal of men's health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Kwangsung Park *Department of Urology, Chonnam National University Medical School, Gwangju, Korea.ORCID https://orcid.org/0000-0001-8827-162X
Hyoung Keun Park *Department of Urology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-7402-8714
Sae Woong KimDepartment of Urology, School of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0002-9127-9400
Dae Yul YangDepartment of Urology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-7331-302X
Jong Kwan ParkDepartment of Urology, Chonbuk National University Medical School, Jeonju, Korea.ORCID https://orcid.org/0000-0001-9682-2081
Hyun Jun ParkDepartment of Urology, Pusan National University School of Medicine, Busan, Korea.ORCID https://orcid.org/0000-0003-0566-9574
Ki Hak MoonDepartment of Urology, Yeungnam University College of Medicine, Daegu, Korea.ORCID https://orcid.org/0000-0002-8193-9022
Du Geon MoonDepartment of Urology, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-9031-9845
Kweon Sik MinDepartment of Urology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.ORCID https://orcid.org/0000-0002-8506-9706
Hwancheol SonDepartment of Urology, SMG-SNU Boramae Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0001-5033-0153
Sung Won LeeDepartment of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-6608-9050
Jae Seog HyunDepartment of Urology, Gyeongsang National University School of Medicine, Jinju, Korea.ORCID https://orcid.org/0000-0002-8820-4117
Woo Suk ChoiDepartment of Urology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8352-578X
Sang Kuk YangDepartment of Urology, Konkuk University Chungju Hospital, Konkuk University School of Medicine, Chungju, Korea. yskurol@kku.ac.kr.ORCID https://orcid.org/0000-0002-7377-0992
Konkuk University Medical Center · KRCatholic University of Korea · KRChonnam National University Hospital · KRGyeongsang National University · KRHallym University · KRInje University Busan Paik Hospital · KRJeonbuk National University · KRKonkuk University · KRKorea University · KRSamsung Medical Center · KRSNUH SMG-SNU Boramae Medical Center · KRYeungnam University College

Funding

Astellas Pharma
6 · The paper itself

Abstract

purposeThe purpose of this study was to evaluate the efficacy of treatment in patients with non-bothering nocturia. MATERIALS AND

methodsIn this prospective multicenter study, patients who visited hospitals for treatment of voiding symptoms were enrolled. Inclusion criteria were: 1) men >45 years, and 2) nocturia ≥2 confirmed by a three-day voiding diary. Subjects were divided into non-bothering and bothering groups based on International Consultation on Incontinence Questionnaire Nocturia (ICIQ-N) question 2b. Changes in voiding symptoms, frequency of nocturia, and bothersomeness were evaluated with international prostate symptom score (IPSS), ICIQ-N, and three-day voiding diary at 4 and 12 weeks after treatment.

resultsA total of 48 patients in the non-bothering nocturia group and 50 patients in the bothering nocturia group who completed the 12-week treatment were analyzed. The total IPSS was decreased by 5.8 in the non-bothering group and 5.2 in the bothering group. There was no significant difference in decrease of IPSS between the two groups. Both groups showed significant reduction in discomfort of nocturia. The ICIQ-N 2b score decreased from 3.9 to 2.7 (p=0.01) in the non-bothering group and from 6.9 to 4.6 (p=0.02) in the bothering group. The number of nocturia episodes was significantly decreased in both groups.

conclusionsRegardless of discomfort associated with nocturia, both groups showed significant improvement in nocturia-related discomfort and voiding symptoms. These results suggest that patients with nocturia who were unaware of its discomfort benefited from treatment.

Indexed as

Lower urinary tract symptomsNocturiaProstatic hyperplasiaTherapeutics

Identifiers

PMID29774671
PMCPMC6119851
OpenAlexW2805025247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.